A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid

Journal of Hepatology

Volumn 42, Issue 6, 2005, Pages 897-906

  Castro, Rui E ^a,b   Solá, Susana ^a   Ma, Xiaoming ^b   Ramalho, Rita M ^a   Kren, Betsy T ^b   Steer, Clifford J ^b   Rodrigues, Cecília M P ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Apaf 1; Bile acids; Cyclin D1; DNA microarrays; Liver; p53

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CADHERIN; CYCLIN D1; PROTEIN P53; PROTHYMOSIN ALPHA; SYNAPSIN I; TAUROURSODEOXYCHOLIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; URSODEOXYCHOLIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; GENE EXPRESSION; GENE IDENTIFICATION; HIGH MOBILITY GROUP BOX DOMAIN; HYBRIDIZATION; IMMUNOBLOTTING; INCUBATION TIME; LIVER CELL; MODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELLS, CULTURED; CHOLAGOGUES AND CHOLERETICS; GENE EXPRESSION; HEPATOCYTES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; TAUROCHENODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

EID: 18844397275     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.01.026     Document Type: Article

References (35)

1. G. Paumgartner, and U. Beuers Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited Hepatology 36 2002 525 531
2. C.M.P. Rodrigues, G. Fan, P.Y. Wong, B.T. Kren, and C.J. Steer Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production Mol Med 4 1998 165 178
3. C.M.P. Rodrigues, G. Fan, X. Ma, B.T. Kren, and C.J. Steer A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation J Clin Invest 101 1998 2790 2799
4. R. Botla, J.R. Spivey, H. Aguilar, S.F. Bronk, and G.J. Gores Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection J Pharmacol Exp Ther 272 1995 930 938
5. C.M.P. Rodrigues, X. Ma, C. Linehan-Stieers, G. Fan, B.T. Kren, and C.J. Steer Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation Cell Death Differ 6 1999 842 854
6. F. Azzaroli, W. Mehal, C.J. Soroka, L. Wang, J. Lee, and N. Crispe Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes Hepatology 36 2002 49 54
7. Q. Xie, V.I. Khaoustov, C.C. Chung, J. Sohn, B. Krishnan, and D.E. Lewis Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation Hepatology 36 2002 592 601
8. S. Solá, X. Ma, R.E. Castro, B.T. Kren, C.J. Steer, and C.M.P. Rodrigues Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor β1-induced apoptosis of rat hepatocytes J Biol Chem 278 2003 48831 48838
9. C. Rust, L.M. Karnitz, C.V. Paya, J. Moscat, R.D. Simari, and G.J. Gores The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade J Biol Chem 275 2000 20210 20216
10. L. Qiao, A. Yacoub, E. Studer, S. Gupta, X.Y. Pei, and S. Grant Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes Hepatology 35 2002 779 789
11. M.H. Schoemaker, L. Conde de la Rosa, M. Buist-Homan, T.E. Vrenken, R. Havinga, and K. Poelstra Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways Hepatology 39 2004 1563 1573
12. B.Y. Tung, M.J. Emond, R.C. Haggitt, M.P. Bronner, M.B. Kimmey, and K.V. Kowdley Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis Ann Intern Med 134 2001 89 95
13. L. Serfaty, A. De Leusse, O. Rosmorduc, B. Desaint, J.F. Flejou, and O. Chazouilleres Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study Hepatology 38 2003 203 209
14. D.L. Earnest, H. Holubec, R.K. Wali, C.S. Jolley, M. Bissonette, and A.K. Bhattacharyya Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid Cancer Res 54 1994 5071 5074
15. G.M. Garbo, M.G. Vicente, V. Fingar, and D. Kessel Effects of ursodeoxycholic acid on photodynamic therapy in a murine tumor model Photochem Photobiol 78 2003 407 410
16. C.N. Mariash, S. Seelig, H.L. Schwartz, and J.H. Oppenheimer Rapid synergistic interaction between thyroid hormone and carbohydrate on mRNAS14 induction J Biol Chem 261 1986 9583 9586
17. C. Li, and W. Hung Wong Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application Genome Biol 2 2001 RESEARCH0032
18. C. Li, and W.H. Wong Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection Proc Natl Acad Sci USA 98 2001 31 36
19. H. Zou, W.J. Henzel, X. Liu, A. Lutschg, and X. Wang Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 Cell 90 1997 405 413
20. S.M. Srinivasula, M. Ahmad, T. Fernandes-Alnemri, and E.S. Alnemri Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization Mol Cell 1 1998 949 957
21. P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, and E.S. Alnemri Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 1997 479 489
22. X. Jiang, H.E. Kim, H. Shu, Y. Zhao, H. Zhang, and J. Kofron Distinctive roles of PHAP proteins and prothymosin-α in a death regulatory pathway Science 299 2003 223 226
23. M.C. Moroni, E.S. Hickman, E.L. Denchi, G. Caprara, E. Colli, and F. Cecconi Apaf-1 is a transcriptional target for E2F and p53 Nat Cell Biol 3 2001 552 558
24. S. Solá, R.E. Castro, P.A. Laires, C.J. Steer, and C.M.P. Rodrigues Tauroursodeoxycholic acid prevents amyloid-β peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway Mol Med 9 2003 226 234
25. R.M. Ramalho, P.S. Ribeiro, S. Solá, R.E. Castro, C.J. Steer, and C.M.P. Rodrigues Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid β-peptide-induced apoptosis of PC12 cells J Neurochem 90 2004 567 575
26. E.K. Han, S.C. Ng, N. Arber, M. Begemann, and I.B. Weinstein Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis Apoptosis 4 1999 213 219
27. S.G. Tevosian, H.H. Shih, K.G. Mendelson, K.A. Sheppard, K.E. Paulson, and A.S. Yee HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family Genes Dev 11 1997 383 396
28. M. Conacci-Sorrell, J. Zhurinsky, and A. Ben-Ze'ev The cadherin-catenin adhesion system in signaling and cancer J Clin Invest 109 2002 987 991
29. K. Helin Regulation of cell proliferation by the E2F transcription factors Curr Opin Genet Dev 8 1998 28 35
30. S.J. Field, F.Y. Tsai, F. Kuo, A.M. Zubiaga, W.G. Kaelin Jr, and D.M. Livingston E2F-1 functions in mice to promote apoptosis and suppress proliferation Cell 85 1996 549 561
31. K.K. Hunt, J. Deng, T.J. Liu, M. Wilson-Heiner, S.G. Swisher, and G. Clayman Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53 Cancer Res 57 1997 4722 4726
32. B. Ganter, S. Fu, and J.S. Lipsick D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain EMBO J 17 1998 255 268
33. Castro RE, Solá S, Ramalho RM, Steer CJ, Rodrigues CMP. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of Bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. J Pharmacol Exp Ther 2004;311:845-852.
34. R.K. Wali, S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, and J. Hart Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin Cancer Epidemiol Biomarkers Prev 11 2002 1653 1662
35. E. Im, and J.D. Martinez Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells J Nutr 134 2004 483 486